Merit Medical Systems, Inc.
MMSI Healthcare Medical Instruments & Supplies
Merit Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 11.8% from fiscal 2024.
- Revenue
- +8.35%
- EPS
- +50.5%
- Free cash flow
- +50.2%
- Total debt
- +0.61%
Quarter to September 2026, against a year earlier
Follow MMSI
Alert me
Merit Medical Systems, Inc. (MMSI) Price to free cash flow
As of 5 November 2026, Merit Medical Systems, Inc. (MMSI) trades at a price to free cash flow of 23.6×. Over the past ten years it has ranged from 0.0× (March 2020) to 418× (September 2018); the current reading is higher than 9% of that period. That is in line with the Medical Instruments & Supplies industry median of 23.5× and above the Healthcare sector median of 21.1×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 24.5× | (20.37%) |
| FY2024 | 30.8× | (24.04%) |
| FY2023 | 40.6× | (32.13%) |
| FY2022 | 59.8× | 100.76% |
| FY2021 | 29.8× | 12.26% |
| FY2020 | 26.5× | — |
| FY2019 | 0.0× | — |
| FY2018 | 144× | 46.03% |
| FY2017 | 98.6× | 57.38% |
| FY2016 | 62.7× | 36.20% |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Sep 2026 | 22.8× | 10.27% |
| Jun 2026 | 20.7× | 9.78% |
| Mar 2026 | 18.9× | (23.09%) |
| Dec 2025 | 24.5× | 1.54% |
| 43 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| STVN Stevanato Group S.p.A. compare | n/m |
| PLSE Pulse Biosciences, Inc compare | n/m |
| MMED MiniMed Group, Inc. compare | n/m |
| NVST Envista Holdings Corporation compare | 16.4× |
| ICUI ICU Medical, Inc. compare | 21.2× |
| MMSI Merit Medical Systems, Inc. | 23.6× |
| BLCO Bausch + Lomb Corporation compare | 31.4× |
| TFX Teleflex Incorporated compare | 125× |
| ATRC AtriCure, Inc. compare | 129× |
| Medical Instruments & Supplies industry median | 23.5× |
| Healthcare sector median | 21.1× |
| Market median | 14.1× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on MMSI
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement